Alicia K. Morgans

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 30 papers. Top paper: “Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study”.

Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study

The Lancet(2020)10.1016/s0140-6736(20)31187-9

N/A

11.9DataRank · unranked

1804 citations

Toni K. Choueiri, Dimpy P. Shah, Yu Shyr, Samuel M. Rubinstein, Donna R. Rivera +95 more

A Randomized Phase II Study of Androgen Deprivation Therapy with or without Palbociclib in RB-positive Metastatic Hormone-Sensitive Prostate Cancer

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-0024

N/A

1.7DataRank · unranked

59 citations

Stephanie Daignault‐Newton, Scott A. Tomlins, Neeraj Agarwal, Przemyslaw Twardowski, Alicia K. Morgans +11 more

The National Cancer Institute clinical trials planning meeting to address gaps in observational and intervention trials for cancer-related cognitive impairment

JNCI Journal of the National Cancer Institute(2024)10.1093/jnci/djae209

N/A

0.584DataRank · unranked

15 citations

Kathleen Van Dyk, Sheri J. Hartman, Thuy T. Koll, Christina K. Cramer, Glenn J. Lesser +30 more

Pain and Its Association with Survival for Black and White Individuals with Advanced Prostate Cancer in the United States

Cancer Research Communications(2023)10.1158/2767-9764.crc-23-0446

N/A

0.414DataRank · unranked

8 citations

Natalie Slopen, Hannah D. McManus, Karen A. Autio, Alicia K. Morgans, Lawrence McSwain +24 more

COVID-19 severity and cardiovascular outcomes in SARS-CoV-2-infected patients with cancer and cardiovascular disease

Translational Oncology(2023)10.1016/j.tranon.2023.101709

N/A

0.115DataRank · unranked

1 citations

Cassandra Hennessy, Benjamin French, Jeremy L. Warner, Matthew D. Tucker, Daniel Hausrath +62 more

An Expert Review on the Combination of Relugolix With Definitive Radiation Therapy for Prostate Cancer

International Journal of Radiation Oncology*Biology*Physics(2021)10.1016/j.ijrobp.2021.12.005

N/A

0DataRank · unranked

12 citations

Nicholas G. Zaorsky, H.P. Bagshaw, Alejandro Berlín, Alison Tree, Sandra Turner +21 more

Sapanisertib, a dual mTORC1/2 inhibitor, for TSC1- or TSC2-mutated metastatic urothelial carcinoma (mUC).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.6_suppl.431

N/A

0DataRank · unranked

10 citations

Matthew I. Milowsky, Noah M. Hahn, David J. Kwiatkowski, Alicia K. Morgans, Nancy B. Davis +10 more

The 5-Hydroxymethylcytosine Landscape of Prostate Cancer

Cancer Research(2022)10.1158/0008-5472.can-22-1123

N/A

0DataRank · unranked

67 citations

Shuang G. Zhao, Samuel Levy, Meng Zhang, Yuhong Ning, Raunak Shrestha +58 more

Identification and Validation of the Prognostic Impact of Metastatic Prostate Cancer Phenotypes

Clinical Genitourinary Cancer(2022)10.1016/j.clgc.2022.02.008

N/A

0DataRank · unranked

4 citations

Xi Wang, Eric J. Lehrer, Amar U. Kishan, Daniel E. Spratt, Christine Lin +7 more

Association between body mass index and localized prostate cancer management and disease‐specific quality of life

BJUI Compass(2022)10.1002/bco2.197

N/A

0DataRank · unranked

4 citations

Christopher J.D. Wallis, Li‐Ching Huang, Jacob E. Tallman, Zhiguo Zhao, Karen E. Hoffman +15 more

A phase II study of sEphB4-HSA in metastatic castration-resistant prostate cancer.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.6_suppl.084

N/A

0DataRank · unranked

1 citations

Masha Kocherginsky, Sabah Munir, Brenda Martone, Alicia K. Morgans, Walter M. Stadler +3 more

Validation of Biomechanical Computed Tomography for Fracture Risk Classification in Metastatic Hormone-sensitive Prostate Cancer

European Urology Oncology(2023)10.1016/j.euo.2023.10.016

N/A

0DataRank · unranked

12 citations

Caleb Hearn, Emily Getzen, Qi Long, David C. Lee, Tony M. Keaveny +14 more

Quality of life in the year after new diagnosis with advanced prostate cancer for Black and White individuals living in the US

Quality of Life Research(2023)10.1007/s11136-023-03468-0

N/A

0DataRank · unranked

9 citations

Natalie Slopen, Karen A. Autio, Alicia K. Morgans, Lawrence McSwain, Pedro C. Barata +18 more

The Risk of Catastrophic Healthcare Expenditures Among Prostate and Bladder Cancer Survivors in the United States

Clinical Genitourinary Cancer(2023)10.1016/j.clgc.2023.05.016

N/A

0DataRank · unranked

7 citations

Muhieddine Labban, Dejan K. Filipas, Edoardo Beatrici, Stuart R. Lipsitz, Leonardo Oliveira Reis +6 more

Effect of cerebral dopamine metabolism genetic polymorphism on patient-reported quality-of-life (QOL): An analysis of the E3805 CHAARTED trial.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.6_suppl.123

N/A

0DataRank · unranked

1 citations

Yu‐Hui Chen, Christopher Sweeney, David F. Jarrard, Elizabeth R. Plimack, Benjamin A. Gartrell +7 more

Phase III study of local or systemic therapy intensification directed by PET in prostate cancer patients with post-prostatectomy biochemical recurrence (INDICATE): ECOG-ACRIN EA8191.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps5118

N/A

0DataRank · unranked

1 citations

Yu‐Hui Chen, Steve Y. Cho, Fenghai Duan, Christos E. Kyriakopoulos, Alicia K. Morgans +10 more

Phase III study of local or systemic therapy intensification directed by PET in prostate cancer patients with post-prostatectomy biochemical recurrence (INDICATE): ECOG-ACRIN EA8191.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.6_suppl.tps402

N/A

0DataRank · unranked

0 citations

Yu‐Hui Chen, Steve Y. Cho, Fenghai Duan, Christos E. Kyriakopoulos, Alicia K. Morgans +10 more

Patient reported quality of life (QOL) and survival outcomes: Analysis of ECOG-ACRIN E3805 chemohormonal androgen ablation randomized trial (CHAARTED) in prostate cancer (PCa).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.5014

N/A

0DataRank · unranked

0 citations

Xiangying Chu, David F. Jarrard, Michael A. Carducci, Robert S. DiPaola, Lynne I. Wagner +4 more

Salivary toxicity from PSMA-targeted radiopharmaceuticals: What we have learned and where we are going

Cancer Treatment Reviews(2024)10.1016/j.ctrv.2024.102748

N/A

0DataRank · unranked

28 citations

Charles L. Loprinzi, Jacob J. Orme, Regina M. Koch, Ahmed Mahmoud, Adam M. Kase +11 more

Plant‐based diet associated with better quality of life in prostate cancer survivors

Cancer(2024)10.1002/cncr.35172

N/A

0DataRank · unranked

21 citations

Qi Hua, Scott R. Bauer, Stacey A. Kenfield, Alicia K. Morgans, June M. Chan +4 more

Patient-reported Quality of Life and Survival Outcomes in Prostate Cancer: Analysis of the ECOG-ACRIN E3805 Chemohormonal Androgen Ablation Randomized Trial (CHAARTED)

European Urology Oncology(2024)10.1016/j.euo.2024.04.010

N/A

0DataRank · unranked

8 citations

Xiangying Chu, David F. Jarrard, Michael A. Carducci, Robert S. DiPaola, Lynn I. Wagner +4 more

Social integration and long-term physical and psychosocial quality of life among prostate cancer survivors in the Health Professionals Follow-up Study

Journal of Cancer Survivorship(2024)10.1007/s11764-024-01632-0

N/A

0DataRank · unranked

4 citations

Colleen B. McGrath, Konrad H. Stopsack, Alicia K. Morgans, Rachel C. Nethery, Barbra A. Dickerman +2 more

Expert Perspectives on Controversies in Castration-Sensitive Prostate Cancer Management: Narrative Review and Report of the First US Prostate Cancer Conference Part 1

JU Open Plus(2024)10.1097/ju9.0000000000000137

N/A

0DataRank · unranked

7 citations

Alan H. Bryce, Maha Hussain, Neeraj Agarwal, Himisha Beltran, Matthew R. Cooperberg +33 more

Expert Perspectives on Controversies in Metastatic Castration-Resistant Prostate Cancer Management: Narrative Review and Report of the First US Prostate Cancer Conference Part 2

JU Open Plus(2024)10.1097/ju9.0000000000000138

N/A

0DataRank · unranked

3 citations

E. David Crawford, Neeraj Agarwal, Maha Hussain, Himisha Beltran, Matthew R. Cooperberg +33 more

Genetic Drivers of Quality of Life in Prostate Cancer: An Evaluation of Genetic Polymorphisms and Patient-reported Outcomes in the E3805 CHAARTED trial

European Urology Oncology(2025)10.1016/j.euo.2025.04.003

N/A

0DataRank · unranked

1 citations

Xiangying Chu, Charles J. Ryan, Arjun Gupta, Christopher J. Sweeney, David F. Jarrard +10 more

Associations of COVID-19 vaccination with risks for post-infectious cardiovascular complications: an international cohort study in cancer patients with SARS-CoV-2 infection

The Lancet Regional Health - Americas(2025)10.1016/j.lana.2025.101038

N/A

0DataRank · unranked

0 citations

Chih–Yuan Hsu, Sanjay Mishra, Elizabeth A. Griffiths, Brahm H. Segal, Clara Hwang +30 more

What Do Men with Metastatic Prostate Cancer Consider When Making Treatment Decisions? A Mixed-methods Study

Patient Preference and Adherence(2020)10.2147/ppa.s271620

N/A

0DataRank · unranked

16 citations

Frank Schumacher, Brian D. Gonzalez, Kelvin A. Moses, David F. Penson, Alicia K. Morgans +1 more

Androgen receptor inhibitor treatments: Cardiovascular adverse events and comorbidity considerations in patients with non-metastatic prostate cancer

Urologic Oncology Seminars and Original Investigations(2020)10.1016/j.urolonc.2020.08.003

N/A

0DataRank · unranked

41 citations

Neal D. Shore, Diane Cope, Andrea McNatty, Javid J. Moslehi, Leonard G. Gomella +2 more

A pilot study of tazemetostat and MK-3475 (pembrolizumab) in advanced urothelial carcinoma (ETCTN 10183).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.tps607

N/A

0DataRank · unranked

11 citations

Ali Shilatifard, Stephen D. Miller, Alicia K. Morgans, David James VanderWeele, Masha Kocherginsky +2 more

A phase II study of sEphB4-HSA in metastatic castration-resistant prostate cancer (mCRPC).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.tps274

N/A

0DataRank · unranked

1 citations

Vinay Sagar, Borko Jovanovic, Alicia K. Morgans, David James VanderWeele, David I. Quinn +4 more